Atossa Therapeutics (ATOS)'s 30-day implied volatility (IV30) was 102.2% at the close on October 23, 2026, up from 82.1% the day before, against a 52-week range of 50.7% to 125.2%. Its 20-day historical volatility was 126.4%.
Data as of October 23, 2026.